Xenon Pharmaceuticals
XENE
XENE
91 hedge funds and large institutions have $590M invested in Xenon Pharmaceuticals in 2021 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 33 increasing their positions, 24 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
12% more funds holding
Funds holding: 81 → 91 (+10)
2.11% more ownership
Funds ownership: 80.04% → 82.14% (+2.1%)
Holders
91
Holding in Top 10
2
Calls
$3.09M
Puts
–
Top Buyers
| 1 | +$15.2M | |
| 2 | +$9.22M | |
| 3 | +$8.26M | |
| 4 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
+$8.23M |
| 5 |
SCM
Suvretta Capital Management
New York
|
+$7.88M |
Top Sellers
| 1 | -$2.97M | |
| 2 | -$1.38M | |
| 3 | -$1.32M | |
| 4 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
-$1.26M |
| 5 |
GPCM
Granite Point Capital Management
Boston,
Massachusetts
|
-$1.24M |